Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles are valuable for regenerative medicine and wound healing.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

Enzymes called PADIs play a key role in hair growth and loss.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Both mouse and rat models are effective for testing alopecia areata treatments.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.